VANCOUVER – November 10, 2026 -- WAT Medical Enterprise Ltd. is renewing its US$1 donation to The American Legion for every HeadaTerm 2 device sold, marking the eighth consecutive year of the program and widening its veteran-focused support to device donations, purchase discounts and clinical research.
WAT Medical ties veteran giving directly to HeadaTerm 2 unit sales
The per-unit donation to The American Legion links the company's charitable spending to sales volume of HeadaTerm 2, its wearable device. The product is FDA-cleared for the prevention of episodic migraine in adults and is marketed as a portable, drug-free option.
Semper Fi & America's Fund receives HeadaTerm 2 devices for migraine-affected veterans
WAT Medical took part in an in-kind donation initiative with Semper Fi & America's Fund, supplying devices to veterans and service members dealing with migraine. The organization issued the company a certificate of appreciation.
The company also offers additional discounts to veterans and active-duty military personnel. It reports positive feedback from military users of the device.
Giving program dates to 2018 and spans multiple health charities
Charitable giving has been part of WAT Medical's corporate social responsibility efforts since 2018. Recipients have included the Red Cross, the EDS community and MD Anderson Cancer Center.
Mitacs partnership launches clinical research initiative for HeadaTerm 2
Through Mitacs, WAT Medical has introduced a clinical research initiative to further explore HeadaTerm 2's applications in migraine prevention. The company's founder said the aim is to "make a meaningful difference in people's lives" through donations, product contributions, purchasing support and research.